Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/70954| Title: | Pharmacological treatment for the novel coronavirus disease 2019 (COVID-19 infection) |
| Authors: | Nattapong Tidwong Preecha Montakantikul Weerawat Manosuthi |
| Authors: | Nattapong Tidwong Preecha Montakantikul Weerawat Manosuthi |
| Keywords: | Medicine;Pharmacology, Toxicology and Pharmaceutics |
| Issue Date: | 1-Jan-2020 |
| Abstract: | © Faculty of Pharmacy, Mahidol University (Thailand) 2020. As of March 22, 2020, a total of 292,142 confirmed coronavirus disease 2019 (COVID-19) cases have been reported globally. Although there are currently no specific antiviral agents but all coronaviruses shared similar key elements of target for currently approved antiviral or new drug development. Several agents might be considered as a possible treatment based on the efficacy in SARS and MERS. |
| URI: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85085214601&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70954 |
| ISSN: | 25868470 25868195 |
| Appears in Collections: | CMUL: Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.